Adam Ricciardone, global head of self care R&D at Johnson & Johnson Consumer Health, discusses how 70-year-old Tylenol embraced a “beyond-the-pill” strategy, as well as how it fits in the context of the pharma industry’s overall shift toward promoting self-care.